Rahul Banerjee, MD
Fred Hutch/University of Washington Cancer Consortium · University of Washington · University of California, San Francisco
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rahul Banerjee, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:11 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06588660 · ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple MyelomaUniversity of Washington · terminated · Recurrent Multiple Myeloma, Refractory Multiple Myeloma · principal investigator
- N/ANCT05956457 · PRO and Wearable Data Insights From Individuals With R/R Multiple MyelomaPack Health · recruiting · Multiple Myeloma, Relapsed Hematologic Malignancy · principal investigator
- N/ANCT05362331 · Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell TherapyUniversity of California, San Francisco · withdrawn · Lymphoma, Leukemia, Plasma Cell Dyscrasia · principal investigator
- N/ANCT05053607 · Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with IsatuximabPack Health · recruiting · Multiple Myeloma, Refractory Multiple Myeloma · principal investigator
- Ph2NCT04883242 · Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaUniversity of Washington · active not recruiting · Recurrent Multiple Myeloma, Refractory Multiple Myeloma · principal investigator
- N/ANCT04589286 · Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing TransplantationUniversity of California, San Francisco · completed · Multiple Myeloma, Stem Cell Transplant · principal investigator
- N/ANCT04432818 · Digital Life Coaching for Myeloma Patients Undergoing TransplantationUniversity of California, San Francisco · completed · Multiple Myeloma · principal investigator
- Ph2NCT04205409 · Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic MalignanciesUniversity of Washington · completed · Recurrent Chronic Lymphocytic Leukemia, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.